Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the medication pravastatin will ameliorate
renal and cardiovascular disease over a 3-year period in children and young adults with
autosomal dominant polycystic kidney disease (ADPKD).
Phase:
Phase 3
Details
Lead Sponsor:
University of Colorado, Denver
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)